Inflammasome Activation in SARS-CoV-2 Pathogenesis

SARS-CoV-2 infection can precipitate a dysregulated innate immune response in which activation of cytosolic sensor complexes known as inflammasomes plays a central role. These molecular assemblies detect viral RNA or viroporin activity and recruit adaptor proteins to activate caspase-1, leading to the proteolytic maturation of interleukin-1β and interleukin-18. The resulting cytokine release and gasdermin-mediated pore formation drive pyroptotic cell death and amplify local inflammation. Viral factors such as the nucleocapsid protein and ORF3a directly interact with the NLRP3 inflammasome, enhancing complex assembly and promoting lysosomal dysfunction. In severe COVID-19, excessive inflammasome activation contributes to acute respiratory distress syndrome, endothelial injury and multiorgan failure. A deeper understanding of the mechanisms by which SARS-CoV-2 co-opts inflammasome pathways has pointed to therapeutic strategies aimed at blocking caspase-1, inhibiting NLRP3 assembly or modulating upstream host factors to restore immune homeostasis.

Research from Nature Portfolio

Recent studies have demonstrated that the SARS-CoV-2 ORF3a protein hyperactivates the small GTPase Rab7 by sequestering its regulatory GAP, thereby impairing endosome–lysosome fusion and facilitating viral egress. This lysosomal blockade further potentiates inflammasome priming by promoting reactive oxygen species and potassium efflux. Foundational work has also elucidated a direct interaction between the viral nucleocapsid protein and NLRP3, which accelerates recruitment of the ASC adaptor and boosts caspase-1 activation. In vivo models confirm that these viral-host interfaces exacerbate lung injury and elevate levels of IL-1β and IL-6, while small-molecule inhibitors of NLRP3 or caspase-1 effectively attenuate tissue damage and cytokine release.

Inflammasome Activation in SARS-CoV-2 Pathogenesis publication trend

The graph below shows the total number of articles in inflammasome activation in sars-cov-2 pathogenesis across all publications each year (not limited to Nature Index journals).

Technical terms

Inflammasome: A multiprotein sensor complex that activates inflammatory caspases in response to pathogen-associated or damage-associated signals.

NLRP3: A Nod-like receptor that nucleates inflammasome assembly upon detecting cellular stress or viral components.

Pyroptosis: A lytic form of programmed cell death driven by gasdermin pore formation and proinflammatory cytokine release.

Caspase-1: An inflammatory protease that cleaves pro-IL-1β and pro-IL-18 into their active cytokine forms and mediates pyroptosis.

Viroporin: A viral ion channel protein that perturbs host membrane integrity and can trigger inflammasome activation.

References

1. SARS-CoV-2 virulence factor ORF3a blocks lysosome function by modulating TBC1D5-dependent Rab7 GTPase cycle. Nature Communications (2024).
2. Ferroptosis and pyroptosis signatures in critical COVID-19 patients. Cell Death & Differentiation (2023).
3. Vitamin D3 attenuates SARS‐CoV‐2 nucleocapsid protein‐caused hyperinflammation by inactivating the NLRP3 inflammasome through the VDR‐BRCC3 signaling pathway in vitro and in vivo. MedComm (2023).
4. SARS-CoV-2 N protein promotes NLRP3 inflammasome activation to induce hyperinflammation. Nature Communications (2021).
5. Targeting the NLRP3 Inflammasome in Severe COVID-19. Frontiers in Immunology (2020).
6. SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes. Cell Death Discovery (2021).